|
|
|
Volumn 32, Issue 6, 1996, Pages 490-498
|
|
Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat
a
|
|
Author keywords
Apolipoprotein; Atherosclerosis; Gene expression; Hyperlipidemia; Hypolipidemic drugs
|
|
Indexed keywords
BLOOD;
BLOOD VESSELS;
DISEASES;
DRUG PRODUCTS;
DRUG THERAPY;
GENES;
GENETIC ENGINEERING;
METABOLISM;
PHARMACODYNAMICS;
RNA;
TISSUE;
CHOLESTYRAMINE;
GENE EXPRESSION;
HIGH DENSITY LIPOPROTEIN;
HYPOLIPIDEMIC DRUGS;
INTESTINAL APOLIPOPROTEIN;
MRNA;
RAT;
SIMVASTATIN TREATMENT;
LIPIDS;
ANTILIPEMIC AGENT;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN A2;
APOLIPOPROTEIN A4;
CLOFIBRATE;
COLESTYRAMINE;
HIGH DENSITY LIPOPROTEIN;
NICOTINIC ACID;
PROBUCOL;
SIMVASTATIN;
ANIMAL EXPERIMENT;
ARTICLE;
GENE EXPRESSION;
INTESTINE;
LIPOPROTEIN METABOLISM;
LIVER;
MALE;
NONHUMAN;
RAT;
ACTINS;
ANIMALS;
ANTILIPEMIC AGENTS;
APOLIPOPROTEINS;
CHOLESTYRAMINE;
CLOFIBRATE;
GENE EXPRESSION REGULATION;
INTESTINES;
LIPID METABOLISM;
LIPOPROTEINS, HDL;
LIVER;
LOVASTATIN;
MALE;
NIACIN;
PROBUCOL;
PROCETOFEN;
RATS;
RATS, WISTAR;
SIMVASTATIN;
|
|
EID: 0030176037
PISSN: 00212180
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (20)
|
|
References (57)
|
